Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ferric Derisomaltose

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 29,637Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CSL Vifor floats £23M offer to end competition probe in UK
    CSL Vifor floats £23M offer to end competition probe in UK

    11 Dec 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/csl-vifor-floats-ps23m-offer-end-uk-competition-authority-probe-alleged-disinformation

    FIERCE PHARMA
    11 Dec 2024
    Share Share
    Japan approves iron deficiency drug from Pharmacosmos
    Japan approves iron deficiency drug from Pharmacosmos

    29 Mar 2022

    // M.A. Hemmingsen MEDWATCH

    https://medwatch.com/News/Pharma___Biotech/article13868643.ece?utm_campaign=MedWatch%20Newsletter&utm_content=2022-03-28&utm_medium=email&utm_source=medwatch_com

    M.A. Hemmingsen MEDWATCH
    29 Mar 2022
    Share Share
    Monofer (ferric derisomaltose) injection is approved in China for the treatment
    Monofer (ferric derisomaltose) injection is approved in China for the treatment

    10 Feb 2021

    // FIRSTWORDPHARMA

    https://www.firstwordpharma.com/node/1799663?tsid=33

    FIRSTWORDPHARMA
    10 Feb 2021
    Share Share